87 results
8-K
EX-99.1
IMNM
Immunome, Inc.
7 Oct 24
Other Events
7:14pm
under this Plan are referred to in this Plan as “Eligible Employees.” These Awards must be approved by either a majority of the Company’s … Requirements. All Awards must be granted by either a majority of Independent Directors or the Independent Compensation Committee in accordance
424B5
IMNM
Immunome, Inc.
14 May 24
Prospectus supplement for primary offering
8:48am
, the holders of a majority of the shares of our common stock entitled to vote in any election of directors can elect all of the directors standing … , may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum
424B5
rg43ro
14 Feb 24
Prospectus supplement for primary offering
4:09pm
424B5
ig0fdb4tfi
13 Feb 24
Prospectus supplement for primary offering
4:36pm
8-K
EX-99.2
lxlgd5 grmmhn
13 Feb 24
Results of Operations and Financial Condition
4:10pm
S-3ASR
EX-4.4
r0ti6w3
13 Feb 24
Automatic shelf registration
4:04pm
S-3ASR
8gn254fk yza
13 Feb 24
Automatic shelf registration
4:04pm
8-K
EX-2.1
wx0kqkveq
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:05am
8-K
EX-10.1
tjgin z9jv
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:05am
S-8
EX-99.4
mgs7 jqm3a0pkoqlg
2 Feb 24
Registration of securities for employees
4:04pm
8-K/A
EX-99.1
hxhu0lhqq
22 Nov 23
Report of Independent Auditors
4:02pm
8-K/A
EX-99.2
tu8zvnqvp499nv 6y
22 Nov 23
Report of Independent Auditors
4:02pm